HX Diagnostics

HX Diagnostics is a molecular diagnostics company based in Emeryville, California, specializing in the development of rapid, point-of-care (POC) testing platforms. The company's technology is designed to provide high-sensitivity, multiplexed molecular results in a decentralized setting, bridging the gap between laboratory-based PCR and rapid antigen tests. HX Diagnostics gained prominence during the COVID-19 pandemic for its work on high-throughput and rapid diagnostic solutions, supported by initiatives like the NIH's Rapid Acceleration of Diagnostics (RADx) program. The company's leadership includes veterans from the diagnostics industry, focusing on expanding their platform to include a variety of respiratory and infectious disease targets.